We are studying whether telmisartan can lower liver pressure in patients with advanced chronic liver disease and portal hypertension. This trial will also assess its safety and impact on quality of life.
Health conditions and diseases that the clinical trial is designed to study and treat.
Compensated advanced chronic liver disease is a stage of liver disease where the liver is still functioning well enough to perform its essential tasks, but significant damage has occurred. Patients may not show symptoms, but the liver is at risk of further deterioration.
Portal hypertension is a condition characterized by increased blood pressure in the portal vein, which carries blood from the digestive organs to the liver. It can lead to serious complications, including varices and ascites.
These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..
Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.
Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.
Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.